Verapamil hydrochloride injection how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Verapamil}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [CAR...")
 
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AK}}
{{CMG}}; {{AE}} {{AK}}


==HOW SUPPLIED==


Verapamil Hydrochloride Injection, USP 2.5 mg/mL is supplied in single-dose containers as follows:


[[image:verainj3.png]]


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c27c868-7eae-4b3e-babf-e89404ea27b7#nlm34090-1 | publisher =  | date =  | accessdate =  }}</ref>
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
 
Protect from light by retaining in package until ready to use.
 
Revised: March, 2010
 
Printed in USA                            EN-2463
 
Hospira, Inc., Lake Forest, IL 60045 USA
 
Cardinal Health
 
Zanesville, OH 43701
 
IA6892 0612<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c27c868-7eae-4b3e-babf-e89404ea27b7#nlm34090-1 | publisher =  | date =  | accessdate =  }}</ref>





Revision as of 23:59, 4 March 2014

Verapamil
CALAN tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
CALAN SR tablet extended release® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
VERAPAMIL HYDROCHLORIDE injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Verapamil
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

HOW SUPPLIED

Verapamil Hydrochloride Injection, USP 2.5 mg/mL is supplied in single-dose containers as follows:

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Protect from light by retaining in package until ready to use.

Revised: March, 2010

Printed in USA EN-2463

Hospira, Inc., Lake Forest, IL 60045 USA

Cardinal Health

Zanesville, OH 43701

IA6892 0612[1]



References

  1. "VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH]".